Cited by 105Tryptophan and brain disordersNeurotransmitter Receptor Influence on BehaviorTreatment of Major Depression

The effects of high-dose and low-dose tryptophan depletion on mood and cognitive functions of remitted depressed patients

Open access
Booij, Linda, Van der Does, A. J. Willem, Haffmans, P. M. Judith, Riedel, Wim J., Fekkes, Durk, Blom, Marc J. B.·2005·Journal of Psychopharmacology

Abstract

It has frequently been demonstrated that acute tryptophan depletion (ATD) induces a transient depressed mood in some patients who are in remission from depression. However, the effects of ATD on cognitive processes in remitted depressed patients have not been investigated. The aim of the present study was to investigate the effects of different extents of depletion on mood and cognitive tasks involving neutral and emotional stimuli. Twenty patients in remission or in partial remission from depression received ATD in a double-blind, crossover design. Mood was assessed at both sessions before, at +6.5 h and +24 h afterdepletion. Cognitive assessment in both sessions started at +4.75 h, and also before and after the whole procedure. The ATD mixtures induced the expected reductions of plasma tryptophan levels. High-dose ATD induced a depressive response in a subsample of patients and impaired theprocessing of positive information independent of mood change. Attention for neutral stimuli (Stroop interference) improved in a dose-dependent manner. ATD may affect mood and cognition via different pathways: one implicated in mood regulation and the processing ofemotional information, and one for the processing of neutral information. The first pathway may be more important for discriminating vulnerability to impaired serotonin function. The comparison of the effects of high-dose and low-dose ATD is useful for those studies aiming to investigate the relationships among 5-HT, mood and cognition.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0269881105051538

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Booij, L., Van der Does, A. J. W., Haffmans, P. M. J., Riedel, W. J., Fekkes, D., & Blom, M. J. B.
Affiliations
  • Leiden University (NL)
  • Department of Psychology, Leiden University and Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands
  • Parnassia Groep (NL)
  • University of Cambridge (GB)
  • Erasmus MC (NL)
  • Psychomedical Center Parnassia, The Hague, The Netherlands
Venue
Journal of Psychopharmacology
Published
2005-05
Volume
19
Issue
3
Pages
267-275
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W2058087319
Cited by
105
References
8
Citations by year
2025: 2 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 2 · 2019: 3 · 2018: 2 · 2017: 3 · 2016: 5 · 2015: 5 · 2014: 7 · 2013: 6 · 2012: 4
FWCI
3.90
Type
journal article
Language
en
Locations
  • Journal of Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders
  • Erasmus Medisch Centrum
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • Stichting tot Steun Vereniging tot Christelijke Verzorging van Geestes- en Zenuwzieken
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
tryptophan depletion, acute tryptophan depletion, remitted depression, partial remission, mood, cognitive function, emotional processing, Stroop interference, attention, serotonin, dose-dependent effects, plasma tryptophan
MeSH terms
Adolescent, Adult, Affect, Aged, Cognition, Depressive Disorder, Dose-Response Relationship, Drug, Double-Blind Method, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Pattern Recognition, Visual, Psychiatric Status Rating Scales, Psychomotor Performance, Reaction Time, Tryptophan, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review